Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Oncology | Family Medicine

Adenocarcinoma Clinical Trials


A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Huntsville : Clearview Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Arizona

Scottsdale : Scottsdale Healthcare

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Scottsdale : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Scottsdale : Translational Genomics Research Institute (TGen)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Scottsdale : Mayo Clinic Arizona

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Tucson : University of Arizona Health Sciences Center

A clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Tucson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Tucson : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Arkansas

Fayetteville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Hot Springs : Genesis Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

California

Corona : Comprehensive Cancer Care Medical Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Duarte :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Duarte : City of Hope, Site #009

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Duarte : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Fountain Valley : Compassionate Care Research Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Hollywood : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

La Jolla :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

La Jolla : Moores Cancer Center University of California, San Diego, Site #099

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Jolla : UC San Diego Moores Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Los Angeles : Cedars Sinai Medical Center

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Los Angeles : Cedars Sinai Medical Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Los Angeles : USC Norris Comprehensive Cancer Center

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Los Angeles : Cedars-Sinai Medical Center Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Los Angeles : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oxnard : Ventura County Hematology-Oncology Specialists Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pasadena : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Redondo Beach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Riverside : Compassionate Cancer Care Medical Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Sacramento : UC Davis Comprehensive Cancer Center

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Sacramento : UC Davis Comprehensive Cancer Center

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Sacramento : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Diego : Kaiser Permanente, Site #208

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

San Francisco : University of California San Francisco UCSF (SC)

A clinical research study of LDE225 and BKM120

San Francisco : University of California San Francisco

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Francisco : UCSF - Mount Zion

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Santa Monica : University of California, Los Angeles Medical Center (UCLA)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Whittier :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Whittier : Innovative Clinical Research Institute

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Colorado

Aurora : University of Colorado Cancer Center

A clinical research study of Ponatinib

Aurora : University of Colorado Cancer Center, Site #015

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Aurora : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Aurora : University of Colorado Anschutz Medical Campus

Patients are needed to participate in a clinical research study of IMMU-132

Denver : Rocky Mountain Cancer Centers Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Edwards : The Shaw Regional Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Pueblo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Connecticut

Farmington : University of Connecticut Health Center

A Phase 2 clinical study for patients with Ovarian Neoplasms

Hartford : Saint Francis Hospital and Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Delaware

Newark : Christina Care Health System

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Newark : Helen F. Graham Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Florida

Boca Raton : Lynn Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boca Raton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Deerfield Beach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Fort Myers :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Fort Myers : Florida Cancer Specialists - South

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Fort Myers : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville : University of Florida

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Jacksonville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Jacksonville : Mayo Clinic Jacksonville

A clinical research study of Tumor markers for the treatment of Pancreatic Adenocarcinoma

Jacksonville : Mayo Clinic Florida

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Lake Worth : Cancer Center of South Florida, Site #204

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Miami : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Miami :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Miami Beach : Mount Sinai Medical Center CCOP

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Ocala : Ocala Oncology Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Orlando : Florida Hospital Cancer Institute

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Orlando : Florida Hospital Cancer Institute Memorial System

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study of IMMU-132

Pembroke Pines : Memorial Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pensacola : Woodlands Medical Specialists

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Pensacola : Sacred Heart Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Pensacola : Sacred Heart Medical Oncology Group - Davis Highway

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sarasota : Florida Cancer Specialists / Sarah Cannon Research Institute

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

St. Petersburg :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

St. Petersburg : Florida Cancer Specialists-North

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

St. Petersburg : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tampa :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Tampa :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Tampa : H. Lee Moffitt Cancer Center

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Tampa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tampa : Moffitt Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Georgia

Savannah : Memorial University Medical Center

RTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Atlanta : Emory University

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Atlanta : Piedmont Hospital Research Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Atlanta : Winship Cancer Institute of Emory University, Site #058

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Atlanta : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Augusta : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Gainesville : Northeast Georgia Medical Center

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Marietta : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Marietta :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Illinois

Arlington Heights : Illinois Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Arlington Heights :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Chicago : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chicago : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Evanston : Northshore University Healthsystem Research Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Peoria : Illinois Cancer Care - Peoria

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Quincy : Quincy Medical Group - Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Indiana

Goshen : Indiana University Health Goshen Center for Cancer Care Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Goshen : IU Health Goshen Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Indianapolis :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Indianapolis : IU Simon Cancer Center

Patients are needed to participate in a clinical research study evaluating porfimer sodium, endoscopic ultrasonography, photodynamic therapy and gemcitabine hydrochloride for the treatment of Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas or Stage III Pancreatic Cancer

Indianapolis : Investigative Clinical Research of Indiana, LLC

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Lafayette :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Mishawaka : Michiana Hematology Oncology PC-Mishawaka

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

South Bend : Northern Indiana Cancer Research Consortium

A Phase 2 clinical study for patients with Ovarian Neoplasms

Terre Haute : RHHP/Hope Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Westville : Michiana Hematology Oncology-PC Westville

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa

Ames : McFarland Clinic Oncology

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Bettendorf : Hematology Oncology Associates - Quad Cities

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Davenport : Genesis Medical Center - East Campus

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa City : VA Medical Center - University of Iowa

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Kansas

Topeka :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Wichita : Cancer Center of Kansas Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Kentucky

Ashland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Louisville : CBC Group Consulting in Blood Disorders and Cancer, PSC

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Paducah : Western Kentucky Hematology and Oncology Group Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Louisiana

Marrero : West Jefferson Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Marrero : Crescent City Research Consortium

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

New Orleans : Ochsner Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Maine

Augusta : Harold Alfond Center for Cancer Care

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Bangor : Eastern Maine Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Maryland

Baltimore : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1/Phase 2 clinical study for patients with Resectable Pancreatic Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Bethesda : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Easton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Frederick : Frederick Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Massachusetts

Boston : Dana Farber Cancer Institute Dana SC

A clinical research study of LDE225 and BKM120

Boston : Beth Israel Deaconess Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Dana Farber Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Massachusetts General Hospital Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Massachusettes General Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Rockland : Please Contact U.S. Medical Information Located in Updated

A clinical trial seeking patients for a research study for the treatment of Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Michigan

Ann Arbor : University of Michigan

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Ann Arbor : University of Michigan

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Ann Arbor : Saint Joseph Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Phase 1 clinical study for patients using LGK974

Detroit : Karmanos Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit : Henry Ford Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Escanaba : Green Bay Oncology - Escanaba

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Grand Rapids : Grand Rapids Oncology Program

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Iron Mountain : Green Bay Oncology - Iron Mountain

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Livonia : Saint Mary Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Saginaw : Saint Mary's of Michigan

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Minnesota

Coon Rapids : Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Duluth : Essentia Health Duluth Clinic CCOP

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Rochester : Mayo Clinic - Rochester Division of Hematology

A clinical research study of LDE225 and BKM120

Rochester : Mayo Clinic

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Shakopee : Saint Francis Regional Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis Park : Park Nicollet Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stillwater : Lakeview Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Woodbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Woodbury :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Missouri

Bridgeton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cape Girardeau : Saint Francis Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Chesterfield : Saint Luke's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Columbia : University of Missouri - Ellis Fischel

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Jefferson City :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Springfield : Mercy Hospital - Springfield

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

St. Louis : Missouri Baptist Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis : Washington University School of Medicine

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Montana

Billings : Saint Vincent Healthcare

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Bozeman : Bozeman Deaconess Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Nebraska

Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Omaha : UNMC Eppley Cancer Center at the University of Nebraska Medical Center

A clinical trial seeking patients for a research study of ADH-1, cisplatin, gemcitabine hydrochloride and laboratory biomarker analysis

Omaha : Methodist Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Omaha : Nebraska Methodist Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Omaha :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nevada

Henderson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-Tenaya

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-San Martin

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Vegas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New Hampshire

Concord : New Hampshire Oncology - Hematology PA

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Dover : Wentworth Douglass Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Hooksett : New Hampshire Oncology Hematology Associates

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Laconia : LRGHealthcare-Lakes Region General Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Lebanon : Dartmouth-Hitchcock Norris Cotton Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

New Jersey

Basking Ridge : Memoral Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Basking Ridge : Memorial Sloan-Kettering Cancer Center at Basking Ridge

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Basking Ridge : Memoral Sloan Kettering Cancer Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Basking Ridge : Memoral Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

East Brunswick : Regional Cancer Care Associates Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Livingston : Saint Barnabas Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Morristown : Regional Cancer Care Associates/ Carol G. Simon Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New Mexico

Albuquerque : University of New Mexico

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Cruces : Memorial Medical Center-Las Cruces

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Santa Fe : Christus Saint Vincent Regional Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New York

Brooklyn : Maimonides Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Buffalo : Roswell Park Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer or Unspecified Adult Solid Tumor, Protocol Specific

Buffalo : Roswell Park Cancer Institute

A clinical trial to evaluate treatments using vorinostat, temsirolimus, laboratory biomarker analysis and positron emission tomography/computed tomography for patients

Buffalo : Roswell Park Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Commack : Memorial Sloan-Kettering Cancer Center at Commack

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Commack : Memorial Sloan Kettering Cancer Center @ Suffolk

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Hudson :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Jamaica : Queens Cancer Center of Queens Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New Hyde Park : Long Island Jewish Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma or Distal Esophageal Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center 1275 York Avenue

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Small Cell Prostate Cancer, Neuroendocrine Prostate Cancer or Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using degarelix injection and androgen deprivation therapy for patients with Prostate Cancer or Prostatic Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

New York : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

New York : Columbia University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New York : Weill Cornell/New York Presbyterian Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Rochester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Rochester : University of Rochester Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Rockville Centre : Memorial Sloan-Kettering Cancer Center at Mercy Medical Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Rockville Centre : Memorial Sloan Kettering at Mercy Medical Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Sleepy Hollow : Memorial Sloan-Kettering Cancer Center Sleepy Hollow

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Sleepy Hollow : Memoral Sloan Kettering Cancer Center at Phelps

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

North Carolina

Asheboro : Randolph Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Chapel Hill : University of North Carolina at Chapel Hill

A clinical study for patients with Barrett's Esophagus, Intestinal Metaplasia or Intramucosal Adenocarcinoma

Chapel Hill : UNC - Chapel Hill

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Chapel Hill : UNC Health Care; N.C. Cancer Hospital Infusion/Inpatient Pharmacy (CHIP)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chapel Hill : University of North Carolina

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Chapel Hill : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Charlotte : Novant Health Presbyterian Medical Center

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Novant Health Presbyterian Medical Center, Site #205

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Charlotte : Levine Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Lung Cancer, NSCLC or NSCLC Adenocarcinoma

Durham : Duke University Medical Center Duke - Baker

A clinical research study of LDE225 and BKM120

Durham : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Greensboro : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Greensboro : Core Health Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Reidsville : Annie Penn Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Washington : Marion L. Shepard Cancer Center at Beaufort County Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Winston-Salem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Winston-Salem : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

North Dakota

Bismarck : Sanford Bismarck Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Fargo : Sanford Clinic North-Fargo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Fargo : Sanford Medical Center-Fargo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Ohio

Canton :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Canton :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Canton :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Cincinnati :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Cincinnati : Oncology Hematology Care

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Cincinnati : Oncology Hematology Care Inc.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cleveland : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Cleveland : Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Cleveland : Case Western Reserve University

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Columbus : The Ohio State University

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

A clinical trial to evaluate treatments using panitumumab, irinotecan hydrochloride, fluorouracil and leucovorin calcium for patients

Columbus : Ohio State University Comprehensive Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : Ohio State University Medical Center

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Oklahoma

Lawton : Cancer Centers of Southwest Oklahoma, LLC - Lawton

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Oklahoma City : University of Oklahoma Peggy and Charles Stephenson Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Oklahoma City : University of Oklahoma Health Sciences Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Tulsa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oregon

Corvallis : Good Samaritan Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Eugene : Willamette Valley Clinical Studies Williamette Valley Cancer

A clinical research study of LDE225 and BKM120

Eugene :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Portland : Northwest Cancer Specialists Main Site

A clinical research study of LDE225 and BKM120

Portland : Oregon Health and Sciences University

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Portland : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : Kaiser Permanente Health Care - Portland

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Portland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Pennsylvania

Gettysburg : Adams Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Philadelphia : Fox Chase Cancer Center FCCC

A clinical research study of LDE225 and BKM120

Philadelphia : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Philadelphia : University of Pennsylvania

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Philadelphia : University of Pennsylvania

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Philadelphia : Thomas Jefferson University Updated

Patients are needed to participate in a clinical research study evaluating Cabazitaxel, Intensity Modulated Radiation Therapy (IMRT), Anti-Androgen Therapy: Bicalutamide and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist for the treatment of Prostate Cancer

Philadelphia : Thomas Jefferson University Updated

Patients are needed to participate in a clinical research study of Alisertib, Abiraterone acetate and Prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Enzalutamide, Goserelin acetate, Leuprolide acetate and Radiation therapy

Pittsburgh : University of Pittsburgh Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pittsburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pittsburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

PIttsburgh : Allegheny Singer Research Institute- West Penn

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

York : WellSpan Health-York Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

South Carolina

Charleston :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Charleston : Medical Universtiy of South Carolina (MUSC)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

South Dakota

Sioux Falls : Sanford Cancer Center Oncology Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Watertown : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tennessee

Chattanooga :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Chattanooga : Chattanooga Oncology and Hematology Associates

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Chattanooga : Tennessee Oncology - Chattanooga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chattanooga : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Germantown : The Jones Clinic

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Knoxville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Knoxville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Knoxville : The University of Tennessee Medical Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Knoxville : Center for Biomedical Research

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Nashville : Tennessee Oncology

A clinical research study of MORAb-066

Nashville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Nashville :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nashville : Tennessee Oncology

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Nashville : Vanderbilt University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Tennessee Oncology PLLC

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Texas

Amarillo : Texas Oncology, P.A. Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Arlington : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Arlington : Texas Health Physicians Group

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Arlington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Beaumont : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Beaumont :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bedford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bedford :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Dallas : Mary Crowley Cancer Center

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Dallas : Sammons Cancer Center - Texas Oncology SC-2

A clinical research study of LDE225 and BKM120

Dallas :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Dallas : Baylor University Medical Center at Dallas Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Dallas :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Dallas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dallas : UT Southwestern Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dallas : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Denton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Fort Worth :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Fort Worth : Center for Cancer and Blood Disorders

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Houston : UT MD Anderson Cancer Center

A clinical research study of Abraxane for the treatment of Colorectal Cancer or Cancer of Gastrointestinal Tract

Houston : Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Houston : University of Texas/MD Anderson Cancer Center SC-3

A clinical research study of LDE225 and BKM120

Houston : MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Houston : University of Texas/MD Anderson Cancer Center MD Anderson 2

A Phase 1 clinical study for patients using LGK974

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Gastrointestinal Cancer

Houston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Houston : UT MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Capecitabine, Oxaliplatin and Bevacizumab for the treatment of Gastrointestinal Cancers

Houston : Westchase Clinical Associates/Westchase Oncology Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Houston : M.D. Anderson Cancer Center

Patients are needed to participate in a clinical research study of selinexor to evaluate Prostate Cancer

Houston : The University of Texas M. D. Anderson Cancer Center

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Longview : Texas Oncology, P.A./Longview Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Plano :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Round Rock :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Antonio : Cancer Therapy and Research Center (CTRC), The University of Texas Health Science Center at San Antonio

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Utah

Salt Lake City : University of Utah / Huntsman Cancer Institute Huntsman

A clinical research study of LDE225 and BKM120

Virginia

Richmond : Virginia Commonwealth University

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Washington

Bellingham : PeaceHealth Saint Joseph Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Everett : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poulsbo : Harrison Health Partners Hematology and Oncology - Poulsbo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Seattle : Swedish Health Services

A clinical study for patients with Lung Cancer, NSCLC or Lung Adenocarcinoma

Seattle : Swedish Medical Center Cancer Institute

A clinical research study of AUY922 and Cetuximab

Seattle : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seattle : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Seattle : Seattle Cancer Care Alliance

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle : Virginia Mason Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle : Virginia Mason Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Spokane Valley : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tacoma : Northwest Medical Specialties Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Tacoma : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vancouver : Northwest Cancer Specialists, PC Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

West Virginia

Huntington : Saint Mary's Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Wisconsin

Green Bay : Green Bay Oncology at Saint Vincent Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Green Bay : Saint Mary's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Green Bay : Saint Vincent Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Madison : University of Wisconsin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Manitowoc : Holy Family Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Marshfield : Marshfield Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Marshfield : Saint Joseph's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Milwaukee : Medical College of Wisconsin

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Oconto Falls : Green Bay Oncology - Oconto Falls

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sheboygan : Saint Nicholas Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stevens Point : Saint Michael's Hospital Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stevens Point : Marshfield Clinic at Saint Michael's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sturgeon Bay : Green Bay Oncology - Sturgeon Bay

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Weston : Marshfield Clinic - Weston Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Weston : Diagnostic and Treatment Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Argentina

Ciudad Autonoma de Buenos Aires : Instituto de Oncologia Angel H. Roffo

A clinical research study of CIGB300 for the treatment of Squamous Cell Carcinoma of the Cervix or Adenocarcinoma of the Cervix

Australia

Bentleigh East : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Bentleigh East : Monash Medical Centre Moorabbin Campus

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Douglas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Elizabeth Vale : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Garran : The Canberra Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Heidelberg : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heidelberg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Herston : Royal Brisbane & Women's Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Kurralta Park : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Kurralta Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Malvern : Cabrini Hospital Malvern

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Randwick : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ringwood East : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

South Brisbane : Icon Cancer Care South Brisbane

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St Leonards : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

St Leonards : Northern Cancer Institute, St Leonards

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sydney : Prince of Wales Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tweed Heads : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Austria

Graz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Innsbruck : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krems : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kufstein : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Linz : A.ö. Krankenhaus der Elisabethinen

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Linz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Salzburg : New

A clinical research study for the treatment of Prostate Cancer

Salzburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wels : Klinikum Wels-Grieskirchen GmbH

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wels : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wien : New

A clinical research study for the treatment of Prostate Cancer

Wien : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Wien : Kaiser Franz Josef Spital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Belgium

Antwerpen : New

A clinical research study for the treatment of Prostate Cancer

Bonheiden : New

A clinical research study for the treatment of Prostate Cancer

Brasschaat : New

A clinical research study for the treatment of Prostate Cancer

Brussels : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brussels : Hôpital Erasme

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Brussels : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brussels : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bruxelles : Hôpital Erasme

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Charleroi : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Charleroi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edegem : New

A clinical research study for the treatment of Prostate Cancer

Edegem : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Edegem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edegem : UZ Antwerpen

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gent : New

A clinical research study for the treatment of Prostate Cancer

Gent : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Gent : UZ Gent

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gent : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Haine St. Paul : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Jette : AZ VUB

A Phase 2 clinical study for patients with Lung Neoplasms, Non-Small Cell Lung Cancer or Adenocarcinoma, Bronchiolo-Alveolar

Kortrijk : New

A clinical research study for the treatment of Prostate Cancer

Leuven : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leuven : UZ Leuven

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Liege : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Liège : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Oostende : New

A clinical research study for the treatment of Prostate Cancer

Ottignies : New

A clinical research study for the treatment of Prostate Cancer

Roeselare : New

A clinical research study for the treatment of Prostate Cancer

Roeselare : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Turnhout : New

A clinical research study for the treatment of Prostate Cancer

Yvoir : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bosnia and Herzegovina

Banja Luka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Banja Luka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tuzla : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brazil

Pelotas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santo Andre : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sao Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sao Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

São Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bulgaria

Plovdiv : Multiprofile Hospital for Active Treatment "Central Onco Hospital", Plovdiv, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Plovdiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Shumen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Military Medical Academy - Multiprofile Hospital for Active Treatment, Sofia, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : Multiprofile Hospital for Active Treatment "Serdika", Sofia, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : University Multiprofile Hospital for Active Treatment "Tsaritsa Yoanna - ISUL", Sofia, Clinic of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Varna : Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Clinic of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Varna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Canada

Edmonton : Cross Cancer Institute

A clinical research study of Irinotecan-Capecitabine-Oxaliplatin for the treatment of Gastrointestinal Neoplasm or Gastric Adenocarcinoma

Edmonton : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Greenfield Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Laval : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montreal : Montreal General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Jewish General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montreal : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Toronto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toronto : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vancouver : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

China

Beijing : Chinese People's Liberation Army (PLA) General Hospital

A clinical trial seeking patients for a research study for the treatment of EGFR Positive Non-small Cell Lung Cancer or Adenocarcinoma

Beijing : Cancer Insititute and Hospital,Chinese Academy of Medical Sciences

A clinical trial seeking patients for a research study for the treatment of Liver Cancer or Pancreatic Adenocarcinoma

Beijing : Cancer Hospital, Chinese Academy of Medical Sciences

A Phase 2 clinical study for patients with Adenocarcinoma of the Gastroesophageal Junction or Esophageal Carcinoma

Beijing : Peking Unicersity Cancer Hospital

A Phase 3 clinical study for patients with Advanced Gastric Carcinoma

Beijing : Department of GI Oncology, Peking University, School of Oncology

Patients are needed to participate in a clinical research study evaluating Paclitaxel, capecitabine and cisplatin for the treatment of Advanced Gastric Cancer

Beijing : Beijing Cancer Hospital

Patients are needed to participate in a clinical research study of SOX sequential S-1 to evaluate Biliary Tract Cancer, Periampullary Adenocarcinoma or Pancreatic Cancer

Changchun : The First Bethune Hospital of Jilin Univercity

A Phase 3 clinical study for patients with NSCLC

Chengdu : Sichuan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Harbin : Harbin Medical Univercity Cancer Hospital

A Phase 3 clinical study for patients with NSCLC

Shenyang : The First Hospital of China Medical University

A Phase 3 clinical study for patients with NSCLC

Shijiazhuang : Hebei Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Xian : Xijing Hospital

A Phase 3 clinical study for patients with NSCLC

Zhengzhou : Henan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Croatia

Zagreb : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Czech Republic

Horovice : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hradec Kralove : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olomouc : University Hospital Olomouc, Clinic of Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Olomouc : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olomouc : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ostrava : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Praha 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Usti nad Labem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Zlin : Krajska nemocnice T. Bati a.s.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Znojmo : Hospital Znojmo, Department of Radiation and Clinical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Denmark

Aalborg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Copenhagen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Odense : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Finland

Helsinki : Helsingin Yliopistollinen Keskussairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Kuopio : Kuopio University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Oulu : Oulu Univerity Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Tampere : Tampereen yliopistollinen sairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tampere : University of Tampere

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Turku : Department of Oncology and Radiotherapy, turku University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Vaasa : Vaasa Distric Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

France

Angers : New

A clinical research study for the treatment of Prostate Cancer

Angers cedex 12 : CHU Angers

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Avignon Cedex 9 : New

A clinical research study for the treatment of Prostate Cancer

Bayonne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Béziers : New

A clinical research study for the treatment of Prostate Cancer

Bordeaux : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Clermont Ferrand Cedex 1 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Creteil : Hopital Henri Mondor

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of Prostate

Creteil : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dijon cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gap : New

A clinical research study for the treatment of Prostate Cancer

Grenoble : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Hyeres : New

A clinical research study for the treatment of Prostate Cancer

Le Mans : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lille : CHRU Lille

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lille : Centre Oscar Lambret

Patients are needed to participate in a clinical research study of Aflibercept-FOLFIRI to evaluate Metastatic Colorectal Cancer

Lyon Cedex 06 : Groupement Hospitalier Edouard Herriot

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lyon Cedex 08 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Marseille : New

A clinical research study for the treatment of Prostate Cancer

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montpellier : New

A clinical research study for the treatment of Prostate Cancer

Montpellier Cedex 5 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nancy : New

A clinical research study for the treatment of Prostate Cancer

Nice cedex 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Paris : New

A clinical research study for the treatment of Prostate Cancer

Paris : Hôpital Européen Georges Pompidou

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Périgueux cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pierre Benite Cedex : New

A clinical research study for the treatment of Prostate Cancer

Pringy : New

A clinical research study for the treatment of Prostate Cancer

Reims : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Reims Cedex : New

A clinical research study for the treatment of Prostate Cancer

Rennes : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Rennes Cedex 09 : New

A clinical research study for the treatment of Prostate Cancer

Saint Priest en Jarez : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

St Gregoire Cedex : New

A clinical research study for the treatment of Prostate Cancer

Strasbourg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Strasbourg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tours Cedex : New

A clinical research study for the treatment of Prostate Cancer

Villejuif : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Germany

Augsburg : New

A clinical research study for the treatment of Prostate Cancer

Bad Nauheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bad Saarow : New

A clinical research study for the treatment of Prostate Cancer

Bautzen : New

A clinical research study for the treatment of Prostate Cancer

Berlin : New

A clinical research study for the treatment of Prostate Cancer

Berlin : Evangelische Lungenklinik Berlin

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Berlin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Berlin : Charité - Universitätsmedizin Berlin Charité Centrum für Tumormedizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Berlin : Charité - Universitätsmedizin Berlin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Berlin : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Bielefeld : Onkologische Schwerpunktpraxis Bielefeld

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Bochum : Universitätsklinikum Knappschaftskrankenhaus Bochum

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Bochum : Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Brandenburg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Braunschweig : New

A clinical research study for the treatment of Prostate Cancer

Braunschweig : Prof. Dr. F. Lordick

A clinical research study of catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel and Fluorouracil, leucovorin, oxaliplatin, docetaxel for the treatment of Gastric Adenocarcinoma With Peritoneal Carcinomatosis, Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis or Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Chemnitz : New

A clinical research study for the treatment of Prostate Cancer

Chemnitz : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Cologne : University of Cologne / LCGC

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Cologne : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cottbus : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Darmstadt : Please Contact Merck Communication Services Located in Updated

A clinical trial seeking patients for a research study for the treatment of Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Dortmund : Klinikum Dortmund gGmbH Medizinische Klinik Mitte

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Dresden : BAG / Onkologische Schwerpunktpraxis

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Dresden : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dresden : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Duisburg : New

A clinical research study for the treatment of Prostate Cancer

Elstra : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Essen : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Essen : Universitätsklinikum Essen, Innere Klinik Tumorforschung

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Essen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Frankfurt : Institut für Klinische Forschung, Krankenhaus Nordwest GmbH

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Frankfurt a.M. : Universitätsklinikum Frankfurt - Medizinische Klinik II

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Frankfurt am Main : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Freiburg : Universitätsklinikum Freiburg, Innere Medizin II

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Freital : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Fürstenwalde : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Gauting : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Grosshansdorf : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Halle/Saale : Universitätsklinikum Halle/Saale; Poliklinik für innere Medizin iV

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Halle/Saale : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Hamburg : New

A clinical research study for the treatment of Prostate Cancer

Heidelberg : Thoraxklinik Heidelberg

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Heidelberg : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Herne : Medizinische Klinik III - Hämatologie/Onkologie Marienhospital Herne

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Jena : New

A clinical research study for the treatment of Prostate Cancer

Kassel : Klinikum Kassel GmbH Medizinischen Klinik IV;Onkologie,

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Kiel : New

A clinical research study for the treatment of Prostate Cancer

Kirchheim : New

A clinical research study for the treatment of Prostate Cancer

Köthen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Kronach : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Lebach : Gemeinschaftspraxis für Hämatologie und Onkologie

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Leipzig :

A clinical research study for the treatment of Non-Small Cell Lung Cancer

Leipzig : Universitätsklinikum Leipzig, Klinik und Poliklinik für Gastroenterologie und Rheumatologie

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Leipzig : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leipzig : Hospital

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Leipzig : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Leubeck : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Magdeburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Magdeburg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Mainz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mainz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Mannheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Meiningen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Mühlhausen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Munich : University of Munich

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Münster : Hämatologisch-Onkologische Gemeinschaftspraxis

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Nürnberg : Klinikum Nürnberg Nord Medizinische Klinik 5

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Nürtingen : New

A clinical research study for the treatment of Prostate Cancer

Offenbach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Parchim : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Pinneberg : Onkologische Schwerpunktpraxis Pinneberg

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Plauen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Regensburg : Klinik und Poliklinik für Innere Medizin I Universitätsklinikum Regensburg

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Remscheid : New

A clinical research study for the treatment of Prostate Cancer

Reutlingen : New

A clinical research study for the treatment of Prostate Cancer

Rostock : New

A clinical research study for the treatment of Prostate Cancer

Scheibenberg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Schweinfurt : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Schwerin : New

A clinical research study for the treatment of Prostate Cancer

Sindelfingen : New

A clinical research study for the treatment of Prostate Cancer

Stuttgart : Klinikum Stuttgart Klinik Hämatologie, Onkologie und Palliativmedizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Torgau : Clinic

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Tübingen : New

A clinical research study for the treatment of Prostate Cancer

Ulm : New

A clinical research study for the treatment of Prostate Cancer

Ulm : Universitätsklinikum Ulm Zentrum für Innere Medizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Weiden : New

A clinical research study for the treatment of Prostate Cancer

Werdau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Wilhelmshaven : New

A clinical research study for the treatment of Prostate Cancer

Würselen : New

A clinical research study for the treatment of Prostate Cancer

Zittau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Zwickau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Greece

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Heraklion : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heraklion : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Larissa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nea Kifissia, Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Patra : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hong Kong

Hong Kong : Queen Mary Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Hungary

Budapest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Budapest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Debrecen : Debreceni Egyetem Orvos-és Egészségtudományi Centrum

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Deszk : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Gyor : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nyiregyhaza : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szeged : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szekesfehervar : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szolnok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Israel

Haifa : Rambam medical Center

A clinical trial to evaluate treatments using Capecitabine (Xeloda) for patients with Adenocarcinoma Clear Cell

Italy

Ancona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Ancona : Az Osp University Ospedali Riuniti umberto I GM Lancisi Gsalesi

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Aviano PN : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Brescia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Catania : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Firenze : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Firenze : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Firenze : Azienda Ospedaliera Universitaria Careggi

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Meldola : Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Milano : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Milano : Ospedale San Raffaele S.r.l.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Napoli : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pisa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Roma : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Rome : Università Cattolica del Sacro Cuore

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Rozzano MI : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

San Giovanni Rotondo : Ospedale Casa Sollievo Della Sofferenza IRCCS

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Torino : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Japan

Chuo-ku :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Fukuoka-shi : Kyushu University

A clinical research study of Tumor markers for the treatment of Pancreatic Adenocarcinoma

Japan : Zeria Investigative sites

A clinical research study of Z-360 and Placebo for the treatment of Metastatic Pancreatic Adenocarcinoma

Kobe :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Nagoya :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Natori :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Osaka-Sayama :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Korea, Republic of

Busan : Gosin University Gospel Hospital

Patients are needed to participate in a clinical research study of Erlotinib and Silybin-phytosome to evaluate Carcinoma, Non-Small-Cell Lung

Daegu : Kyungpook National University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Daegu : Kyungpook National University Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Dong-gu : Ulsan University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Gangnam-gu : Samsung Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : National Cancer Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : National Cancer Center

Patients are needed to participate in a clinical research study evaluating Gefitinib, Placebo and Pemetrexed plusCIsplatin for the treatment of Non Small Cell Lung Cancer or Adenocarcinoma

Jongno-gu : Seoul National University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Korea : Zeria Investigative Sites

A clinical research study of Z-360 and Placebo for the treatment of Metastatic Pancreatic Adenocarcinoma

Namdong-Gu : Gachon University Gil Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Songpa-gu : Asan Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Latvia

Daugavpils : Daugavpils Regional Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Liepaja : Piejuras Hospital, Oncology Clinic

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Riga : Riga East University Hospital, LLC

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Luxembourg

Luxembourg : New

A clinical research study for the treatment of Prostate Cancer

Niederkorn : New

A clinical research study for the treatment of Prostate Cancer

Malaysia

Kuala Lumpur : University Malaya Medical Centre

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Mexico

Cuernavaca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Distrito Federal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mexico : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toluca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Netherlands

Amsterdam : Academic Medical Center

Patients are needed to participate in a clinical research study to evaluate Barrett'S-associated Dysplasia or Intramucosal Adenocarcinoma

Assen : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Harderwijk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Maastricht : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Rotterdam : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Utrecht : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zwolle : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poland

Bialystok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bydgoszcz : New

A clinical research study for the treatment of Prostate Cancer

Elblag : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gdansk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gdynia : New

A clinical research study for the treatment of Prostate Cancer

Konin : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Konin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krakow : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lodz : New

A clinical research study for the treatment of Prostate Cancer

Lodz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olsztyn : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Opole : New

A clinical research study for the treatment of Prostate Cancer

Otwock : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Poznan : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poznañ : New

A clinical research study for the treatment of Prostate Cancer

Prabuty : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szczecin : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warsaw : New

A clinical research study for the treatment of Prostate Cancer

Warsaw : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warszawa : New

A clinical research study for the treatment of Prostate Cancer

Warszawa : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Warszawa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Portugal

Aveiro : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Braga : New

A clinical research study for the treatment of Prostate Cancer

Coimbra : New

A clinical research study for the treatment of Prostate Cancer

Evora : New

A clinical research study for the treatment of Prostate Cancer

Guimaraes : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lisboa : New

A clinical research study for the treatment of Prostate Cancer

Lisboa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Porto : New

A clinical research study for the treatment of Prostate Cancer

Porto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santa Maria da Feira : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Setubal : New

A clinical research study for the treatment of Prostate Cancer

Vila Real : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Romania

Alba Iulia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baia Mare : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Brasov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Craiova : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Iasi : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lasi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Timisoara : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Russian Federation

Arkhangelsk : Arkhangelsk Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Bryansk : Bryansk Regional Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Chelyabinsk : Chelyabinsk Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Chelyabinsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ekaterinbourg : New

A clinical research study for the treatment of Prostate Cancer

Ivanovo : Ivanovo Regional Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ivanovo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kazan : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krasnodar : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Krasnodar : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kursk : Kursk Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Moscow : Blokhin Russian Oncology Research Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Moscow : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Moscow N/A : New

A clinical research study for the treatment of Prostate Cancer

Novgorod : Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Obninsk : New

A clinical research study for the treatment of Prostate Cancer

Obninsk : Medical Radiology Research Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Omsk : New

A clinical research study for the treatment of Prostate Cancer

Omsk : Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Orel : Orel Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Orenburg : Orenburg Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Pyatigorsk : Pyatigorsk Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ryazan : Ryazan Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Saint-Petersburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Samara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

St. Petersburg : First Pavlov State Medical University of St. Petersburg

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : St. Petersburg Clinical Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : Nikiforov Russian Center for Emergency and Radiology Medicine

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : City Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ufa : New

A clinical research study for the treatment of Prostate Cancer

Vladimir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Yaroslavl : Regional Clinical Oncology Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Serbia

Belgrade :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Knez Selo :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Kragujevac : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nis : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sremska Kamenica :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Sremska Kamenica : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Singapore

Singapore :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Slovakia

Bardejov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bratislava : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poprad : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Trencin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Slovenia

Celje : New

A clinical research study for the treatment of Prostate Cancer

Golnik : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ljubljana : New

A clinical research study for the treatment of Prostate Cancer

Ljubljana : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Slovenj Gradec : New

A clinical research study for the treatment of Prostate Cancer

South Africa

Cape Town : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Groenkloof : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Johannesburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kraaifontein : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pretoria : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Spain

A Coruña : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Asturias : New

A clinical research study for the treatment of Prostate Cancer

Badalona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : New

A clinical research study for the treatment of Prostate Cancer

Barcelona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Barcelona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Barcelona : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Barcelona : Hospital Universitario Vall d'Hebron

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Barcelona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : ACROSS

Patients are needed to participate in a clinical research study evaluating bevacizumab for the treatment of Rectal Neoplasms or Locally Advanced Rectal Adenocarcinoma

Bilbao Vizcaya : New

A clinical research study for the treatment of Prostate Cancer

Elche : Hospital General Universitario de Elche

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Fuenlabrada : Hospital Universitario de Fuenlabrada

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

Instituto Catalan de Oncologia de Hospitalet (ICO) : Instituto Catalan de Oncologia de Hospitalet (ICO)

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

La Coruña : New

A clinical research study for the treatment of Prostate Cancer

La Coruña : Centro Oncológico de Galícia

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

L'Hospitalet de Llobregat : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

L'Hospitalet de Llobregat, Barcelona : Institut Català d'Oncologia

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Madrid : Centro Integral Oncológico Clara Campal

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Hospital Universitario Ramon y Cajal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario 12 de Octubre

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Centro Integral Oncologico Clara Campal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Madrid Norte Sanchinarro

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Hospital Universitario Madrid Sanchinarro

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

Madrid : Hospital 12 de Octubre

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Madrid : Ramon Y Cajal

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Malaga : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Malaga : Hospital Regional Universitario de Malaga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Malaga : Hospital Universitario Carlos Haya

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Oviedo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Palma De Mallorca : New

A clinical research study for the treatment of Prostate Cancer

Pamplona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pamplona : Complejo Hospitalario de Navarra

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pontevedra : New

A clinical research study for the treatment of Prostate Cancer

Santander : Hospital Universitario Marques de Valdecilla

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Santander : Hospital Universitario Santander

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Santiago de Compostela : Hospital Clinico Universitario de Santiago

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sevilla : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Sevilla : Hospital Virgen del Rocio

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Terrassa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Valencia : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Valladolid : New

A clinical research study for the treatment of Prostate Cancer

Zaragoza : New

A clinical research study for the treatment of Prostate Cancer

Sweden

Eskilstuna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Göteborg : New

A clinical research study for the treatment of Prostate Cancer

Malmö : New

A clinical research study for the treatment of Prostate Cancer

Örebro : New

A clinical research study for the treatment of Prostate Cancer

Stockholm : New

A clinical research study for the treatment of Prostate Cancer

Stockholm : Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Dept. of Oncology-Pathology, Karolinska University Hospital, Solna

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Umeå : New

A clinical research study for the treatment of Prostate Cancer

Switzerland

Aarau : New

A clinical research study for the treatment of Prostate Cancer

Bellinzona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bern : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chur : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Winterthur : New

A clinical research study for the treatment of Prostate Cancer

Zurich : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Taiwan

Taipei :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Taiwan : Zeria Investigative Sites

A clinical research study of Z-360 and Placebo for the treatment of Metastatic Pancreatic Adenocarcinoma

Turkey

Ankara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gaziantep : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Istanbul : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Izmir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ukraine

Dnipropetrovsk : Dnipropetrovsk City Multispecialty Clinical Hospital #4, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Dnipropetrovsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Donetsk : Donetsk Regional Antitumor Center, Oncosurgery Department #6D

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Donetsk : Donetsk Regional Antitumor Center, Thoracic Department #2

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ivano-Frankivsk : Regional Clinical Oncology Center, Department of Abdominal Surgery

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kharkiv : Kharkiv Regional Clinical Oncology Center, Abdominal Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kharkiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kherson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kyiv : Kyiv City Clinical Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kyiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lutsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lviv : Lviv State Regional Treatment and Diagnostics Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Lviv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mariupol : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poltava : Poltava Regional Clinical Oncology Center, Thoracic Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Simferopol : Clinical Diagnostics Center, LLC, Treatment and Diagnostics Center, Department of Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sumy : Sumy Regional Clinical Oncology Center, Oncothoracic Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sumy : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Uzhgorod : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Uzhhorod : Zakarpattia Regional Clinical Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Zaporizhia : Zaporizhia Regional Clinical Oncology Center, Department of Surgery (Abdominal)

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

United Kingdom

Aberdeen : Aberdeen Royal Infirmary Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Ashton Under Lyne : New

A clinical research study for the treatment of Prostate Cancer

Barnstaple : New

A clinical research study for the treatment of Prostate Cancer

Belfast : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Blackburn : New

A clinical research study for the treatment of Prostate Cancer

Bournemouth : New

A clinical research study for the treatment of Prostate Cancer

Bournemouth : Royal Bournemouth Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Bradford : New

A clinical research study for the treatment of Prostate Cancer

Bradford : Bradford Royal Infirmary Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Brighton Sussex : New

A clinical research study for the treatment of Prostate Cancer

Bristol : Bristol Haematology and Oncology Centre Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Burton : New

A clinical research study for the treatment of Prostate Cancer

Cambridge : Addenbrookes Hospital

Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)

Cambridge : Addenbrooke's Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Cardiff : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cardiff : Velindre Cancer Center at Velindre Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Carlisle : Cumberland Infirmary Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Crewe : New

A clinical research study for the treatment of Prostate Cancer

Doncaster : Doncaster Royal Infirmary Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Edinburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edinburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Glasgow : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Guildford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Guildford : St. Luke's Cancer Centre at Royal Surrey County Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Huddersfield : New

A clinical research study for the treatment of Prostate Cancer

Huddersfield, West Yorks : Huddersfield Royal Infirmary Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Lancaster : New

A clinical research study for the treatment of Prostate Cancer

Leeds : Leeds Cancer Centre at St. James's University Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Leeds Yorks : New

A clinical research study for the treatment of Prostate Cancer

Leicester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leicester : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lincoln : Lincoln County Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Liverpool : Aintree University Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

London : New

A clinical research study for the treatment of Prostate Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : UCLH (University College London Hospitals)

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

London : Saint Bartholomew's Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

London : St. Mary's Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

London : St. George's Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Maidstone : Mid Kent Oncology Centre at Maidstone Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Manchester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Manchester : Christie Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Merseyside : Clatterbridge Centre for Oncology Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

N/a N/a : New

A clinical research study for the treatment of Prostate Cancer

Newcastle Upon Tyne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Newcastle-Upon-Tyne : Northern Centre for Cancer Treatment at Newcastle General Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Northwood : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nottingham : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nottingham : Nottingham Univeristy Hospitals NHS Trust

Patients are needed to participate in a clinical research study evaluating Iron isomaltoside 1000 for the treatment of Anemia, Esophageal Cancer or Gastric Cancer

Plymouth : New

A clinical research study for the treatment of Prostate Cancer

Plymouth : Derriford Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Poole Dorset : Dorset Cancer Centre Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Reading : Berkshire Cancer Centre at Royal Berkshire Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Rochdale : Rochdale Infirmary Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Salisbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Salisbury : Salisbury District Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Scunthorpe : New

A clinical research study for the treatment of Prostate Cancer

Sheffield : Weston Park Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Slough, Berkshire : Wexham Park Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Southampton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Southampton : Southampton General Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Steeton : New

A clinical research study for the treatment of Prostate Cancer

Stoke On Trent : New

A clinical research study for the treatment of Prostate Cancer

Sutton : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Sutton : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sutton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sutton : Royal Marsden - Surrey Updated

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Taunton : New

A clinical research study for the treatment of Prostate Cancer

Torquay : New

A clinical research study for the treatment of Prostate Cancer

Wakefield : New

A clinical research study for the treatment of Prostate Cancer

Wigan : New

A clinical research study for the treatment of Prostate Cancer

York : New

A clinical research study for the treatment of Prostate Cancer

 

Kidney & Urology Foundation of America | 152 Madison Ave, Suite 201 | New York, NY 10016 | 1.800.633.6628
©

About Us | Patient Resources | Professional Resources | Support Us | News & Recent Events | Brochures
Corporate Sponsors | Contact Us | Terms of Use | Privacy Policy

Website Last Modified: October 28, 2010
Donate Today Donate Your Car Join KUFA Now